News
Ahead of the launch, the firm has taken steps to amplify its production capacities to ensure adequate supply, and believes ...
Hims wasn’t stepping back enough from its practice of mass marketing compounded versions of the weight-loss medicine, said ...
Hims & Hers Health Inc.'s stock booked record losses Monday after pharmaceutical giant Novo Nordisk, maker of the weight-loss drug Wegovy, said it was ending a collaboration with the telehealth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results